Addex to Present at the Jefferies 2011 Global Healthcare Conference in London 25.09.2011 | Nachricht

DAX	6.229	-0,8%	Dow	12.372	-0,4%	Euro	1,2363	-0,0%
ESt50	2.107	-0,4%	Nas	2.810	-1,0%	Öl	102,4	-0,8%
TDax	747,5	-0,5%	Nikkei	8.543	-1,1%	Gold	1.558	-0,3%

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Depot
Times + Sales	Chart-Analyse	Analysen	Dividende/HV	Profil	Optionsscheine	Watchlist
Börsenplätze	Chartvergleich	Kursziele	Vergleich	Insidertrades	Knock-outs	myHome
Orderbuch	Realtime Stuttgart	RSS Feed		im Forum	Fonds	Senden/Drucken
Historisch	Realtime Push	myNews neu	Ausblick	IR-Daten	Anleihen	handeln

Relevant
Alle
vom Unternehmen

Sprache:
Alle
DE
EN

Sortieren:
Datum
meistgelesen

09.05.12	PRESS RELEASE: Addex Shareholders Approve All Board Proposals at Annual General Meeting (Dow Jones)
28.11.11	Thomson Reuters ONE/Addex Scientists Discover Glucagon-like-peptide-1 (GLP-1) Induced Interaction Between GLP-1 and Gastric Inhibitory Peptide (GIP) Recep... (Dow Jones)
24.10.11	Thomson Reuters ONE/Addex to Present at the BIO Investor Forum in San Francisco (Dow Jones)
19.10.11	Thomson Reuters ONE/Addex to Present in NYC at the Newsmakers in the Biotech Industry conference hosted by BioCentury and Thomson Reuters (Dow Jones)
03.10.11	Thomson Reuters ONE/Addex to Present Progress on -2- (Dow Jones)
03.10.11	Thomson Reuters ONE/Addex to Present Progress on Multiple Allosteric Modulator Programs for Neurodegenerative and other Neurological Disorders (Dow Jones)
02.09.11	Thomson Reuters ONE/Addex Regains Rights to Parkinson's Drug Candidates from Merck (Dow Jones)
11.08.11	Thomson Reuters ONE/Addex Pharmaceuticals Announces Board Changes (Dow Jones)

09.05.12	PRESS RELEASE: Addex Shareholders Approve All Board Proposals at Annual General Meeting (Dow Jones)
09.05.12	Addex Shareholders Approve All Board Proposals at Annual General Meeting (Addex Pharmaceuticals Ltd.)
04.05.12	Addex Completes Rightsizing of its Operations (Addex Pharmaceuticals Ltd.)
19.04.12	DAX schließt schwach -- Deutsche Bank dementiert Pläne um Kapitalerhöhung -- Dow Jones und Nasdaq im Minus -- Bank of America mit Gewinneinbruch -- Nokia im Fokus (finanzen.net)
16.04.12	Addex Reports Positive Preclinical Data for GABA-BR PAM Oral Small Molecule in Overactive Bladder (Addex Pharmaceuticals Ltd.)
13.04.12	Addex Takes Steps to Rightsize Operations and Position the Company for Future Success (Addex Pharmaceuticals Ltd.)
21.03.12	Addex changes name to Addex Therapeutics (Addex Pharmaceuticals Ltd.)
21.03.12	Addex Reports Positive Top Line Phase IIa Data for Dipraglurant in Parkinson's Disease Levodopa-Induced Dyskinesia (PD-LID) (Addex Pharmaceuticals Ltd.)

09.05.12	Addex Shareholders Approve All Board Proposals at Annual General Meeting (Addex Pharmaceuticals Ltd.)
04.05.12	Addex Completes Rightsizing of its Operations (Addex Pharmaceuticals Ltd.)
16.04.12	Addex Reports Positive Preclinical Data for GABA-BR PAM Oral Small Molecule in Overactive Bladder (Addex Pharmaceuticals Ltd.)
13.04.12	Addex Takes Steps to Rightsize Operations and Position the Company for Future Success (Addex Pharmaceuticals Ltd.)
21.03.12	Addex changes name to Addex Therapeutics (Addex Pharmaceuticals Ltd.)
21.03.12	Addex Reports Positive Top Line Phase IIa Data for Dipraglurant in Parkinson's Disease Levodopa-Induced Dyskinesia (PD-LID) (Addex Pharmaceuticals Ltd.)
22.02.12	Addex Pharmaceuticals Reports 2011 Financial Results (Addex Pharmaceuticals Ltd.)
21.02.12	Addex Pharmaceuticals 2011 Financial Results this Thursday (Addex Pharmaceuticals Ltd.)

09.05.12	PRESS RELEASE: Addex Shareholders Approve All Board Proposals at Annual General Meeting (Dow Jones)
28.11.11	Thomson Reuters ONE/Addex Scientists Discover Glucagon-like-peptide-1 (GLP-1) Induced Interaction Between GLP-1 and Gastric Inhibitory Peptide (GIP) Recep... (Dow Jones)
24.10.11	Thomson Reuters ONE/Addex to Present at the BIO Investor Forum in San Francisco (Dow Jones)
19.10.11	Thomson Reuters ONE/Addex to Present in NYC at the Newsmakers in the Biotech Industry conference hosted by BioCentury and Thomson Reuters (Dow Jones)
03.10.11	Thomson Reuters ONE/Addex to Present Progress on -2- (Dow Jones)
03.10.11	Thomson Reuters ONE/Addex to Present Progress on Multiple Allosteric Modulator Programs for Neurodegenerative and other Neurological Disorders (Dow Jones)
02.09.11	Thomson Reuters ONE/Addex Regains Rights to Parkinson's Drug Candidates from Merck (Dow Jones)
11.08.11	Thomson Reuters ONE/Addex Pharmaceuticals Announces Board Changes (Dow Jones)

Keine Nachrichten im Zeitraum eines Jahres in dieser Kategorie verfügbar.
Eventuell finden Sie Nachrichten, die älter als ein Jahr sind, im Archiv

09.05.12	PRESS RELEASE: Addex Shareholders Approve All Board Proposals at Annual General Meeting (Dow Jones)
19.04.12	DAX schließt schwach -- Deutsche Bank dementiert Pläne um Kapitalerhöhung -- Dow Jones und Nasdaq im Minus -- Bank of America mit Gewinneinbruch -- Nokia im Fokus (finanzen.net)
28.11.11	Thomson Reuters ONE/Addex Scientists Discover Glucagon-like-peptide-1 (GLP-1) Induced Interaction Between GLP-1 and Gastric Inhibitory Peptide (GIP) Recep... (Dow Jones)
28.11.11	Addex Scientists Discover Glucagon-like-peptide-1 (GLP-1) Induced Interaction Between GLP-1 and Gastric Inhibitory Peptide (GIP) Receptors (Hugin)
24.10.11	Thomson Reuters ONE/Addex to Present at the BIO Investor Forum in San Francisco (Dow Jones)
24.10.11	Addex to Present at the BIO Investor Forum in San Francisco (Hugin)
19.10.11	Thomson Reuters ONE/Addex to Present in NYC at the Newsmakers in the Biotech Industry conference hosted by BioCentury and Thomson Reuters (Dow Jones)
19.10.11	Addex to Present in NYC at the Newsmakers in the Biotech Industry conference hosted by BioCentury and Thomson Reuters (Hugin)

09.05.12	Addex Shareholders Approve All Board Proposals at Annual General Meeting (Addex Pharmaceuticals Ltd.)
04.05.12	Addex Completes Rightsizing of its Operations (Addex Pharmaceuticals Ltd.)
16.04.12	Addex Reports Positive Preclinical Data for GABA-BR PAM Oral Small Molecule in Overactive Bladder (Addex Pharmaceuticals Ltd.)
13.04.12	Addex Takes Steps to Rightsize Operations and Position the Company for Future Success (Addex Pharmaceuticals Ltd.)
21.03.12	Addex changes name to Addex Therapeutics (Addex Pharmaceuticals Ltd.)
21.03.12	Addex Reports Positive Top Line Phase IIa Data for Dipraglurant in Parkinson's Disease Levodopa-Induced Dyskinesia (PD-LID) (Addex Pharmaceuticals Ltd.)
22.02.12	Addex Pharmaceuticals Reports 2011 Financial Results (Addex Pharmaceuticals Ltd.)
21.02.12	Addex Pharmaceuticals 2011 Financial Results this Thursday (Addex Pharmaceuticals Ltd.)

28.11.11	Addex Scientists Discover Glucagon-like-peptide-1 (GLP-1) Induced Interaction Between GLP-1 and Gastric Inhibitory Peptide (GIP) Receptors (Hugin)
24.10.11	Addex to Present at the BIO Investor Forum in San Francisco (Hugin)
19.10.11	Addex to Present in NYC at the Newsmakers in the Biotech Industry conference hosted by BioCentury and Thomson Reuters (Hugin)
03.10.11	Addex to Present Progress on Multiple Allosteric Modulator Programs for Neurodegenerative and other Neurological Disorders (Hugin)
02.09.11	Addex Regains Rights to Parkinson's Drug Candidates from Merck (Hugin)
11.08.11	Addex Pharmaceuticals Announces Board Changes (Hugin)
27.07.11	Addex Pharmaceuticals - Finanzergebnisse 1. Hälfte 2011 (Hugin)
20.07.11	Addex Pharmaceuticals First Half Financial Results on July 27 (Hugin)

09.05.12	Addex Shareholders Approve All Board Proposals at Annual General Meeting (Addex Pharmaceuticals Ltd.)
04.05.12	Addex Completes Rightsizing of its Operations (Addex Pharmaceuticals Ltd.)
16.04.12	Addex Reports Positive Preclinical Data for GABA-BR PAM Oral Small Molecule in Overactive Bladder (Addex Pharmaceuticals Ltd.)
13.04.12	Addex Takes Steps to Rightsize Operations and Position the Company for Future Success (Addex Pharmaceuticals Ltd.)
21.03.12	Addex changes name to Addex Therapeutics (Addex Pharmaceuticals Ltd.)
21.03.12	Addex Reports Positive Top Line Phase IIa Data for Dipraglurant in Parkinson's Disease Levodopa-Induced Dyskinesia (PD-LID) (Addex Pharmaceuticals Ltd.)
22.02.12	Addex Pharmaceuticals Reports 2011 Financial Results (Addex Pharmaceuticals Ltd.)
21.02.12	Addex Pharmaceuticals 2011 Financial Results this Thursday (Addex Pharmaceuticals Ltd.)

09.05.12

PRESS RELEASE: Addex Shareholders Approve All Board Proposals at Annual General Meeting (Dow Jones)

09.05.12

PRESS RELEASE: Addex Shareholders Approve All Board Proposals at Annual General Meeting (Dow Jones)

Keine Nachrichten im Zeitraum eines Monats in dieser Kategorie verfügbar

09.05.12	PRESS RELEASE: Addex Shareholders Approve All Board Proposals at Annual General Meeting (Dow Jones)
09.05.12	Addex Shareholders Approve All Board Proposals at Annual General Meeting (Addex Pharmaceuticals Ltd.)
04.05.12	Addex Completes Rightsizing of its Operations (Addex Pharmaceuticals Ltd.)

09.05.12

PRESS RELEASE: Addex Shareholders Approve All Board Proposals at Annual General Meeting (Dow Jones)

09.05.12	Addex Shareholders Approve All Board Proposals at Annual General Meeting (Addex Pharmaceuticals Ltd.)
04.05.12	Addex Completes Rightsizing of its Operations (Addex Pharmaceuticals Ltd.)

09.05.12	Addex Shareholders Approve All Board Proposals at Annual General Meeting (Addex Pharmaceuticals Ltd.)
04.05.12	Addex Completes Rightsizing of its Operations (Addex Pharmaceuticals Ltd.)

Keine Nachrichten im Zeitraum eines Monats in dieser Kategorie verfügbar

09.05.12	Addex Shareholders Approve All Board Proposals at Annual General Meeting (Addex Pharmaceuticals Ltd.)
04.05.12	Addex Completes Rightsizing of its Operations (Addex Pharmaceuticals Ltd.)

Um Ihnen die Übersicht über die große Anzahl an Nachrichten, die jeden Tag für ein Unternehmen erscheinen, etwas zu erleichtern, haben wir den Nachrichtenfeed in folgende Kategorien aufgeteilt:

Relevant: Nachrichten von ausgesuchten Quellen, die sich im Speziellen mit diesem Unternehmen befassen
Alle: Alle Nachrichten, die dieses Unternehmen betreffen. Z.B. auch Marktberichte die außerdem auch andere Unternehmen betreffen
vom Unternehmen: Nachrichten und Adhoc-Meldungen, die vom Unternehmen selbst veröffentlicht werden

Addex Pharmaceuticals Ltd Act.nom. zu myNews hinzufügen Was ist das?

14.03.11	Addex Pharmaceuticals hold	Vontobel Research
23.02.11	Addex Pharmaceuticals hold	Vontobel Research
15.09.10	Addex Pharmaceuticals hold	Vontobel Research
29.07.10	Addex Pharmaceuticals hold	Vontobel Research
28.07.10	Addex Pharmaceuticals hold	Vontobel Research

14.03.11	Addex Pharmaceuticals hold	Vontobel Research
23.02.11	Addex Pharmaceuticals hold	Vontobel Research
15.09.10	Addex Pharmaceuticals hold	Vontobel Research
29.07.10	Addex Pharmaceuticals hold	Vontobel Research
28.07.10	Addex Pharmaceuticals hold	Vontobel Research

16:47 Uhr	UPDATE: Lufthansa spart auf Kosten des Wachstums
16:44 Uhr	Stabwechsel bei EADS perfekt - Neuer Verwaltungsrats-Chef fehlte
16:42 Uhr	ROUNDUP/Aktien New York: Erneut schwächer - US-Konjunkturdaten enttäuschen
16:39 Uhr	Die Herausforderungen der Deutschen Bank
16:36 Uhr	ROUNDUP: USA drohen China mit Strafzöllen für Windkraftanlagen
16:32 Uhr	Axel Springer: BGH weist Revision gegen Honorarregelungen für freie Journalisten im Wesentlichen zurück
16:31 Uhr	PRESS RELEASE: MorphoSys Announces Election of Two New Supervisory Board Members
16:31 Uhr	Thomson Reuters ONE/MorphoSys gibt Wahl von zwei neuen Aufsichtsratsmitgliedern bekannt

Was halten Sie von nutzergenerierten Chartanalysen auf finanzen.net?
	Ich würde liebend gerne mein Wissen über Chartanalyse dem Publikum von finanzen.net zur Verfügung stellen.
	Ich kenne mich bei Chartanalyse nicht so gut aus, halte nutzergenerierte Chartanalysen aber für einen echten Mehrwert.
	Ich halte nichts von den Methoden der Chartanalyse und habe deshalb auch kein Interesse an nutzergenerierten Analysen.
Direkt zu den Ergebnissen Abstimmen

21.05.2012	Die wertvollsten Fußball-Klubs der Welt
24.04.2012	Die besten Chefs der Welt
12.04.2012	Welche DAX-Konzerne ihre Anleger überschütten
23.04.2012	Mit diesen Autos greifen die Deutschen in China an
29.05.2012	Geheime Einblicke in den Kommunismus

Finanzen.net

Addex Pharmaceuticals Aktie [WKN: A0MSH6 / ISIN: CH0029850754]

25.09.2011 19:10

Addex to Present at the Jefferies 2011 Global Healthcare Conference in London

Kommentare zu diesem Artikel

Nachrichten zu Addex Pharmaceuticals Ltd Act.nom.

Analysen zu Addex Pharmaceuticals Ltd Act.nom.

Newssuche

AKTIEN IN DIESEM ARTIKEL

ANZEIGE

Meistgelesene Addex Pharmaceuticals News 1M

Addex Pharmaceuticals Peer Group News

MEISTGELESENE ARTIKEL

Heute im Fokus

NACHRICHTEN

ANZEIGE

TOP-RANKINGS

Umfrage

Quicklinks

Aktienkurse	Beliebteste Aktien
Realtimekurse	Alle Indizes
Top 50	Tops/Flops
Insiderdaten	Quickcharts
Dividenden	Portfolio